Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Frederick de Serres

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Physiology

Procedures

Genes & Molecular Sequences

Disorders

Concepts & Ideas

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
11
Blanco, Ignacio
8
Fernández-Bustillo, Enrique
6
Malling, Heinrich
4
DeMarini, David
4
Fernandez-Bustillo, Enrique
4
Ong, Tong-man
3
Ghavami, Saeid
3
Grant, William
3
Hashemi, Mohammad
2
Alavian, Seyed Moayed
1
Tindall, Kenneth
1
Ferrarotti, Ilaria
1
Leonardi, Andrea
1
Hoel, David
1
Hsie, AW

Sign-in to see all Coauthors

Publications

TOP 3
de Serres F J; Blanco I; Fernández-Bustillo E
PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data.
Ghavami Saeid; Hashemi Mohammad; de Serres Fredrick J; Bajestani Saeed Naghibzadeh; Mehrabifar Hamid; Leonardi Andrea
Trypsin inhibitory capacity in vernal keratoconjunctivitis.
de Serres F J; Blanco I; Fernández-Bustillo E
Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Frederick de Serres (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2007: de Serres F J; Blanco I; Fernández-Bustillo E
PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2007;67(4):184-208.
2007: Ghavami Saeid; Hashemi Mohammad; de Serres Fredrick J; Bajestani Saeed Naghibzadeh; Mehrabifar Hamid; Leonardi Andrea
Trypsin inhibitory capacity in vernal keratoconjunctivitis.
Investigative ophthalmology & visual science 2007;48(1):264-9.
2006: de Serres F J; Blanco I; Fernández-Bustillo E
Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;28(6):1091-9.
2006: de Serres Frederick J; Blanco Ignacio; Fernández-Bustillo Enrique
Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
COPD 2006;3(3):133-9.
2006: Blanco I; de Serres F J; Fernandez-Bustillo E; Lara B; Miravitlles M
Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;27(1):77-84.
2005: Hashemi Mohammad; Alavian Seyed Moayed; Ghavami Saeid; de Serres Frederick J; Salehi Masoud; Doroudi Taher; Fard Amir Hossain Mahagheghi; Mehrabifar Hamid; Milani Behzad; Shahri Seyed Javad Saeidi
High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran.
Hepatology research : the official journal of the Japan Society of Hepatology 2005;33(4):292-7.
2005: de Serres F J; Luisetti M; Ferrarotti I; Blanco I; Fernández-Bustillo E
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2005;63(3):133-41.
2005: Ghavami Saeid; Hashemi Mohammad; Shahriari Hossain Ali; Bajestani Saeed Naghibzadeh; de Serres Frederick J; Moghaddam Ebrahim Miri; Kazemi Morteza; Alavian Seyed Moayed; Taheri Mohsen; Blanco Ignacio; Fernandez Bustillo Enrique
Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran.
Clinical biochemistry 2005;38(5):425-32.
2005: de Serres Frederick J; Blanco Ignacio; Fernández-Bustillo Enrique
Health implications of alpha1-antitrypsin deficiency in Sub-Sahara African countries and their emigrants in Europe and the New World.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(3):175-84.
2005: Blanco Lgnacio Eduardo; de Serres Frederick Joseph; Fernandez-Bustillo Enrique; Kassam Daniel Al; Arbesú Daniel; Rodríguez Carmen; Torre Juan Carlos
alpha1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia.
Medical hypotheses 2005;64(4):759-69.
2004: Blanco Ignacio; Fernández-Bustillo Enrique; de Serres Frederick J; Alkassam Daniel; Rodríguez Menéndez Carmen
[PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain]
Medicina clínica 2004;123(20):761-5.
2004: Blanco Ignacio; Canto Hortensia; de Serres Frederick Joseph; Fernandez-Bustillo Enrique; Rodríguez Maria Carmen
Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.
The Journal of rheumatology 2004;31(10):2082-5.
2003: de Serres Frederick J
Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.
Environmental health perspectives 2003;111(16):1851-4.
2003: de Serres F J; Blanco I; Fernández-Bustillo E
Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.
Clinical genetics 2003;64(5):382-97.
2003: de Serres F J; Blanco I; Fernández-Bustillo E
Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain.
Clinical genetics 2003;63(6):490-509.
2002: de Serres Frederick J
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.
Chest 2002;122(5):1818-29.
1999: de Serres F J; Brockman H E
Comparison of the spectra of genetic damage in formaldehyde-induced ad-3 mutations between DNA repair-proficient and -deficient heterokaryons of Neurospora crassa.
Mutation research 1999;437(2):151-63.
1997: de Serres F J; Malling H V; Brockman H E; Ong T M
Quantitative and qualitative comparison of spontaneous and chemical-induced specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1997;375(1):53-72.
1997: de Serres F J; Webber B B
Quantitative and qualitative comparisons of spontaneous and radiation-induced specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1997;375(1):37-52.
1995: de Serres F J; Malling H V; Webber B B; Brockman H E
Quantitative and qualitative aspects of spontaneous specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1995;332(1-2):45-54.
1995: de Serres F J; Malling H V; Ong T M
Comparison of the mutagenicity and mutagen specificity of ethylenimine with triethylenemelamine in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1995;328(2):193-205.
1995: de Serres F J; Brockman H E
Ethylene oxide: induction of specific-locus mutations in the ad-3 region of heterokaryon 12 of Neurospora crassa and implications for genetic risk assessment of human exposure in the workplace.
Mutation research 1995;328(1):31-47.
1995: de Serres F J; Malling H V
Triethylenemelamine: induction of specific-locus mutations in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1995;327(1-2):87-111.
1994: Sandhu S S; de Serres F J; Gopalan H N; Grant W F; Svendsgaard D; Velemínský J; Becking G C
Environmental monitoring for genotoxicity with plant systems. Results and recommendations.
Mutation research 1994;310(2):257-63.
1994: Sandhu S S; de Serres F J; Gopalan H N; Grant W F; Velemínský J; Becking G C
Environmental monitoring for genotoxicity with plant systems. An introduction and study design.
Mutation research 1994;310(2):169-73.
1994: de Serres F J; Malling H V
Forward-mutation tests on the antitumor agent ICR-170 in Neurospora crassa demonstrate that it induces gene/point mutations in the ad-3 region and an exceptionally high frequency of multiple-locus ad-3 mutations with closely linked sites of recessive lethal damage.
Mutation research 1994;310(1):15-36.
1994: de Serres F J
Genetic risk assessment and specific-locus mutations in the ad-3 region of Neurospora crassa.
Environmental health perspectives 1994;102 Suppl 1():83-90.
1993: de Serres F J; Brockman H E
Comparison of the spectra of genetic damage in N4-hydroxycytidine-induced ad-3 mutations between nucleotide excision repair-proficient and -deficient heterokaryons of Neurospora crassa.
Mutation research 1993;285(2):145-63.
1992: de Serres F J; Overton L K; Sadler B M
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. XI. Heterozygous effects of gene/point mutations of genotype ad-3A or ad-3B.
Mutation research 1992;269(1):149-69.
1992: de Serres F J; Overton L K; Sadler B M
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. X. Heterozygous effects of multilocus deletion mutations of genotype ad-3A or ad-3B.
Mutation research 1992;267(1):105-24.
1992: de Serres F J
Characteristics of spontaneous and induced specific-locus mutation in the ad-3 region of Neurospora crassa: utilization in genetic risk assessment.
Environmental and molecular mutagenesis 1992;20(4):246-59.
1992: de Serres F J
Development of a specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora: a review.
Environmental and molecular mutagenesis 1992;20(4):225-45.
1991: de Serres F J; Brockman H E
Qualitative differences in the spectra of genetic damage in 2-aminopurine-induced ad-3 mutants between nucleotide excision-repair-proficient and -deficient strains of Neurospora crassa.
Mutation research 1991;251(1):41-58.
1991: de Serres F J
The genetic toxicology of 2-amino-N6-hydroxyadenine in eukaryotic organisms: significance for genetic risk assessment.
Mutation research 1991;253(1):5-15.
1991: de Serres F J; Hoel D G
Objectives of the collaborative study on the genetic toxicology of 2-amino-N6-hydroxyadenine: an exercise in genetic risk assessment.
Mutation research 1991;253(1):1-3.
1991: de Serres F J; Brockman H E; Overton L K
2-Amino-N6-hydroxyadenine induces gene/point mutations and multiple-locus mutations, but not multilocus deletion mutations, in the ad-3 region of a two-component heterokaryon of Neurospora crassa.
Mutation research 1991;253(1):21-32.
1991: Sandhu S S; de Serres F J; Gopalan H N; Grant W F; Veleminsky J; Becking G C
Status report of the International Programme on Chemical Safety's Collaborative Study on plant test systems.
Mutation research 1991;257(1):19-25.
1991: Brockman H E; de Serres F J
Mutagenic potency and specificity of procarbazine in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
Mutation research 1991;246(1):193-204.
1990: de Serres F J
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. VII. Genetic lesions resulting in gene/point mutations at the ad-3B locus have different dose-response relationships.
Mutation research 1990;232(2):115-40.
1990: de Serres F J
Heterozygous effects of X-ray-induced specific locus mutations in the ad-3 region of Neurospora crassa: implications for human genetic risk assessment.
Progress in clinical and biological research 1990;340C():139-50.
1989: Dubins J S; Overton L K; Cobb R R; de Serres F J
Classical and molecular genetic analyses of his-3 mutants of Neurospora crassa. II. Southern blot analyses and molecular mechanisms of mutagenicity.
Mutation research 1989;215(1):39-47.
1989: de Serres F J
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. IV. Irreparable mutants of genotype ad-3A and ad-3B result from multilocus deletion and an unexpectedly high frequency of multiple-locus mutations.
Mutation research 1989;214(2):297-319.
1989: Overton L K; Dubins J S; de Serres F J
Molecular and classical genetic analyses of his-3 mutants of Neurospora crassa. I. Tests for allelic complementation and specific revertibility.
Mutation research 1989;214(2):267-83.
1989: Brockman H E; de Serres F J; Hung C Y; Ong T
Effect of the uvs-2 allele of Neurospora crassa on the mutagenic potency of two N-hydroxylaminopurines and 2-aminopurine in the ad-3 forward-mutation test.
Mutation research 1989;218(1):1-11.
1989: de Serres F J
X-ray-induced specific locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. III. Genetic fine structure analysis of the ad-3 and immediately adjacent genetic regions by means of complementation tests.
Mutation research 1989;211(1):89-102.
1989: de Serres F J
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. II. More extensive genetic tests reveal an unexpectedly high frequency of multiple-locus mutations.
Mutation research 1989;210(2):281-90.
1989: DeMarini D M; Brockman H E; de Serres F J; Evans H H; Stankowski L F; Hsie A W
Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective.
Mutation research 1989;220(1):11-29.
1988: de Serres F J; Miller I R
X-ray-induced specific locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. I. Modification of the heterozygous effects of multilocus deletions covering the ad-3A or ad-3B loci.
Mutation research 1988;201(1):49-64.
1988: de Serres F J
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC topic No. 2. Heterozygous effects of multilocus deletions.
Mutation research 1988;196(1):95-9.
1988: de Serres F J; Brockman H E; Hung C Y
Effect of the homokaryotic state of the uvs-2 allele in Neurospora crassa on formaldehyde-induced killing and ad-3 mutation.
Mutation research 1988;199(1):235-42.
1988: Moore M M; DeMarini D M; de Serres F J; Tindall K R
Mammalian cell mutagenesis, Banbury Conference.
Mutation research 1988;203(1):69-78.
1987: Brockman H E; de Serres F J; Ong T M; Hung C Y
Two N-hydroxylaminopurines are highly mutagenic in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
Mutation research 1987;177(1):61-75.
1986: Griffiths A J; Brockman H E; DeMarini D M; de Serres F J
The efficacy of Neurospora in detecting agents that cause aneuploidy.
Mutation research 1986;167(1-2):35-45.
1986: de Serres F J; Brockman H E
Genetic characterization of the mutagenic activity of environmental chemicals at specific loci in two-component heterokaryons of Neurospora crassa.
Progress in clinical and biological research 1986;209A():209-18.
1985: Brockman H E; de Serres F J; Hung C Y
Effect of the homokaryotic or heterokaryotic state of the uvs-2 allele in Neurospora crassa on mitomycin C-induced killing and ad-3 mutation.
Mutation research 1985;150(1-2):193-202.
1985: de Serres F J; Brockman H E; Hung C Y; Overton L K
Mutagenicity of 2-aminopurine, 6-N-hydroxylaminopurine, and 2-amino-N6-hydroxyadenine in Neurospora crassa.
Basic life sciences 1985;31():381-9.
1984: Brockman H E; de Serres F J; Ong T M; DeMarini D M; Katz A J; Griffiths A J; Stafford R S
Mutation tests in Neurospora crassa. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
Mutation research 1984;133(2):87-134.
1983: van Zeeland A A; Mohn G R; Aaron C S; Glickman B W; Brendel M; de Serres F J; Hung C Y; Brockman H E
Molecular dosimetry of the chemical mutagen ethyl methanesulfonate. Quantitative comparison of the mutagenic potency in Neurospora crassa and Saccharomyces cerevisiae.
Mutation research 1983;119(1):45-54.
1983: de Serres F J; Malling H V
The role of Neurospora in evaluating environmental chemicals for mutagenic activity.
Annals of the New York Academy of Sciences 1983;407():177-85.
1981: Inoue H; Ong T M; de Serres F J
Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. IV. Comparison of dose-response curves for MNNG, 4NQO and ICR-170 induced inactivation and mutation-induction.
Mutation research 1981;80(1):27-41.

Sign-in to see more